| scholarly article | Q13442814 |
| P50 | author | Tanusree Sen | Q64906200 |
| Nilkantha Sen | Q64906214 | ||
| Pampa Saha | Q88112831 | ||
| P2093 | author name string | Pampa Saha | |
| P2860 | cites work | An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003 | Q22241952 |
| Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions | Q24301813 | ||
| Neuroprotection by pharmacologic blockade of the GAPDH death cascade | Q24545207 | ||
| S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide | Q24612303 | ||
| Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein | Q24630045 | ||
| Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis | Q24652801 | ||
| Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice | Q24681736 | ||
| New Features about Tau Function and Dysfunction | Q26750922 | ||
| Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics | Q26822002 | ||
| The Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeleton | Q26864818 | ||
| Neuropathological alterations in Alzheimer disease | Q27003314 | ||
| Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits | Q27314989 | ||
| Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation | Q27319514 | ||
| Memory loss in Alzheimer's disease | Q27687485 | ||
| S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration | Q27694603 | ||
| S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding | Q28256078 | ||
| GAPDH mediates nitrosylation of nuclear proteins | Q28569676 | ||
| GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation | Q28570143 | ||
| HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes | Q28575023 | ||
| The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo | Q28590452 | ||
| Alzheimer's disease | Q29616743 | ||
| Behavioral effects of cocaine mediated by nitric oxide-GAPDH transcriptional signaling | Q30580057 | ||
| Acetylation of tau inhibits its degradation and contributes to tauopathy | Q33703231 | ||
| Acetylation: a new key to unlock tau's role in neurodegeneration | Q33821548 | ||
| Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. | Q34538268 | ||
| Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease | Q34544243 | ||
| Tau aggregation and its interplay with amyloid-β. | Q35008256 | ||
| The acetylation of tau inhibits its function and promotes pathological tau aggregation | Q35059866 | ||
| Neurotrophin-mediated degradation of histone methyltransferase by S-nitrosylation cascade regulates neuronal differentiation | Q35647685 | ||
| Curcumin Improves Amyloid β-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway | Q35675578 | ||
| Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling | Q35742331 | ||
| Tau stabilizes microtubules by binding at the interface between tubulin heterodimers | Q35764234 | ||
| Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies | Q35776950 | ||
| Alzheimer's disease pathogenesis and therapeutic interventions | Q35792226 | ||
| Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity | Q35972860 | ||
| Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus | Q35983214 | ||
| Tau phosphorylation: physiological and pathological consequences | Q35992168 | ||
| Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease | Q36006524 | ||
| Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo | Q36650878 | ||
| A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine | Q36833845 | ||
| Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss | Q36877497 | ||
| Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases | Q36981630 | ||
| Cell death: protein misfolding and neurodegenerative diseases | Q37364552 | ||
| Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance | Q37380168 | ||
| Caspase-2 is essential for c-Jun transcriptional activation and Bim induction in neuron death. | Q37527207 | ||
| Alzheimer's disease and the amyloid-beta peptide | Q37671455 | ||
| Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases | Q37718085 | ||
| Protein modifications involved in neurotransmitter and gasotransmitter signaling | Q37789075 | ||
| Neurotoxicity of amyloid β-protein: synaptic and network dysfunction | Q38023860 | ||
| Redox Regulation of Protein Function via Cysteine S-Nitrosylation and Its Relevance to Neurodegenerative Diseases | Q38041548 | ||
| Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance | Q38936873 | ||
| Treatment with an activator of hypoxia-inducible factor 1, DMOG provides neuroprotection after traumatic brain injury | Q42214423 | ||
| Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer's-like impairment in mice | Q42290204 | ||
| Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. | Q42526585 | ||
| Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. | Q42852011 | ||
| Isoflurane-induced inactivation of CREB through histone deacetylase 4 is responsible for cognitive impairment in developing brain | Q47132194 | ||
| Activation of PERK Elicits Memory Impairment through Inactivation of CREB and Downregulation of PSD95 After Traumatic Brain Injury | Q48124415 | ||
| Optimized protein extraction from cryopreserved brain tissue samples | Q48200393 | ||
| Age-specific incidence of Alzheimer's disease in a community population. | Q50596369 | ||
| Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. | Q52552907 | ||
| P433 | issue | 522 | |
| P577 | publication date | 2018-03-20 | |
| P1433 | published in | Science Signaling | Q7433604 |
| P1476 | title | Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β | |
| P478 | volume | 11 |
| Q91856715 | Fructose-1,6-Bisphosphate Protects Hippocampal Rat Slices from NMDA Excitotoxicity |
| Q92132051 | Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease |
| Q90669787 | The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease |
Search more.